21.11.2023 - WINSTON-SALEM, N.C, Nov. 21, 2023 (GLOBE NEWSWIRE) - ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on preserving kidney function in patients living with chronic . Seite 1
05.09.2023 - WINSTON-SALEM, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) - ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on preserving kidney function in patients suffering from . Seite 1